We selected the neuroblastoma cell line SK‐N‐SH for this study, because it expresses relatively low levels of TOP2A and MDM4 (Fig. 1A) and has a wt‐p53 phenotype (He et al., 2011). The gene discussed is TOP2A; the disease is neuroblastoma.